CFDE Data Portal | Search SLC66A2P2

	Label	Description
	SLC66A2P2 Gene (Entity type)	ENSG00000270480 - SLC66A2 pseudogene 2
	GSE100148 EZH2 inhibition 8 v 5 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE111247 temozolomide LN-308 14 v 6 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE168097 epinephrine 3 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE221329 ERK BRAF inhibition thyroid gland 1 v 7 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE100148 EZH2 inhibition 9 v 5 human up Gene Set (Entity type)	A Gene Set from LINCS
	GTEx Brain 20-29 vs 30-39 Down Gene Set (Entity type)	A Gene Set from GTEx
	GTEx Brain 20-29 vs 50-59 Down Gene Set (Entity type)	A Gene Set from GTEx
	GTEx Spleen 20-29 vs 30-39 Down Gene Set (Entity type)	A Gene Set from GTEx
	GSE158438 lenalidomide IRCC-Neuromed-FL 5 v 9 human up Gene Set (Entity type)	A Gene Set from LINCS

SLC66A2P2

ENSG00000270480 - SLC66A2 pseudogene 2

GSE100148 EZH2 inhibition 8 v 5 human dn

A Gene Set from LINCS

GSE111247 temozolomide LN-308 14 v 6 human up

A Gene Set from LINCS

GSE168097 epinephrine 3 v 2 human dn

A Gene Set from LINCS

GSE221329 ERK BRAF inhibition thyroid gland 1 v 7 human up

A Gene Set from LINCS

GSE100148 EZH2 inhibition 9 v 5 human up

A Gene Set from LINCS

GTEx Brain 20-29 vs 30-39 Down

A Gene Set from GTEx

GTEx Brain 20-29 vs 50-59 Down

A Gene Set from GTEx

GTEx Spleen 20-29 vs 30-39 Down

A Gene Set from GTEx

GSE158438 lenalidomide IRCC-Neuromed-FL 5 v 9 human up

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.